|
HY-103310-50mg
|
MedChemexpress LLC
|
MRS1845 [CAS 544478-19-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103310-1mL
|
MedChemexpress LLC
|
MRS1845 [CAS 544478-19-5] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101308A-5mg
|
MedChemexpress LLC
|
MRS2179 (tetrasodium hydrate)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-108657A-1mg
|
MedChemexpress LLC
|
MRS2279 (diammonium) [CAS 2387505-47-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-136501-5mg
|
MedChemexpress LLC
|
MRS2395 [CAS 491611-55-3]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-108658-10mg
|
MedChemexpress LLC
|
MRS2500 (tetraammonium) [CAS 630103-23-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-108658-2mg
|
MedChemexpress LLC
|
MRS2500 (tetraammonium) [CAS 630103-23-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-108658-5mg
|
MedChemexpress LLC
|
MRS2500 (tetraammonium) [CAS 630103-23-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-108649A-1mg
|
MedChemexpress LLC
|
MRS2768 (tetrasodium salt) [CAS 2567869-47-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-110037-10mg
|
MedChemexpress LLC
|
MRS-3777 (hemioxalate) [CAS 1186195-57-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-110037-25mg
|
MedChemexpress LLC
|
MRS-3777 (hemioxalate) [CAS 1186195-57-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-110037-5mg
|
MedChemexpress LLC
|
MRS-3777 (hemioxalate) [CAS 1186195-57-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-110037-50mg
|
MedChemexpress LLC
|
MRS-3777 (hemioxalate) [CAS 1186195-57-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-110037-1mL
|
MedChemexpress LLC
|
MRS-3777 (hemioxalate) [CAS 1186195-57-2] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-110202-1mg
|
MedChemexpress LLC
|
MRS5698 [CAS 1377273-00-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-117857-10mg
|
MedChemexpress LLC
|
MRT00033659 [CAS 1401731-54-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-117857-100mg
|
MedChemexpress LLC
|
MRT00033659 [CAS 1401731-54-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-117857-5mg
|
MedChemexpress LLC
|
MRT00033659 [CAS 1401731-54-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-117857-50mg
|
MedChemexpress LLC
|
MRT00033659 [CAS 1401731-54-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-108507-1mg
|
MedChemexpress LLC
|
MRT-10 [CAS 330829-30-6]
|
|
Cancer-programmed cell death
|
|
|
HY-108507-10mg
|
MedChemexpress LLC
|
MRT-10 [CAS 330829-30-6]
|
|
Cancer-programmed cell death
|
|
|
HY-108507-25mg
|
MedChemexpress LLC
|
MRT-10 [CAS 330829-30-6]
|
|
Cancer-programmed cell death
|
|
|
HY-108507-5mg
|
MedChemexpress LLC
|
MRT-10 [CAS 330829-30-6]
|
|
Cancer-programmed cell death
|
|
|
HY-108507-50mg
|
MedChemexpress LLC
|
MRT-10 [CAS 330829-30-6]
|
|
Cancer-programmed cell death
|
|
|
HY-108507-1mL
|
MedChemexpress LLC
|
MRT-10 [CAS 330829-30-6] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
